Free Trial

Utah Medical Products (UTMD) Stock Price, News & Analysis

Utah Medical Products logo
$66.45 0.00 (0.00%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$66.63 +0.18 (+0.27%)
As of 05/29/2026 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Utah Medical Products Stock (NASDAQ:UTMD)

Advanced

Key Stats

Today's Range
$66.14
$66.56
50-Day Range
$61.54
$70.65
52-Week Range
$52.00
$71.81
Volume
7,744 shs
Average Volume
9,737 shs
Market Capitalization
$211.31 million
P/E Ratio
19.66
Dividend Yield
1.87%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Utah Medical Products Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

UTMD MarketRank™: 

Utah Medical Products scored higher than 27% of companies evaluated by MarketBeat, and ranked 778th out of 870 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Utah Medical Products has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Utah Medical Products has only been the subject of 1 research reports in the past 90 days.

  • Read more about Utah Medical Products' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Utah Medical Products is 19.66, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.96.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Utah Medical Products is 19.66, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 21.59.

  • Price to Book Value per Share Ratio

    Utah Medical Products has a P/B Ratio of 1.78. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Utah Medical Products' valuation and earnings.
  • Percentage of Shares Shorted

    4.53% of the float of Utah Medical Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Utah Medical Products has a short interest ratio ("days to cover") of 15.39, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Utah Medical Products has recently increased by 4.73%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Utah Medical Products pays a meaningful dividend of 1.87%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Utah Medical Products has only been increasing its dividend for 3 years.

  • Dividend Coverage

    The dividend payout ratio of Utah Medical Products is 36.69%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Utah Medical Products' dividend.
  • News Sentiment

    Utah Medical Products has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Utah Medical Products this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Utah Medical Products insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    8.00% of the stock of Utah Medical Products is held by insiders.

  • Percentage Held by Institutions

    69.60% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Utah Medical Products' insider trading history.
Receive UTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UTMD Stock News Headlines

Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.31
See More Headlines

UTMD Stock Analysis - Frequently Asked Questions

Utah Medical Products' stock was trading at $55.96 at the start of the year. Since then, UTMD stock has increased by 18.7% and is now trading at $66.45.

Utah Medical Products, Inc. (NASDAQ:UTMD) issued its earnings results on Thursday, April, 23rd. The medical instruments supplier reported $0.82 EPS for the quarter. The medical instruments supplier earned $8.72 million during the quarter. Utah Medical Products had a net margin of 28.90% and a trailing twelve-month return on equity of 9.13%.

Utah Medical Products' top institutional shareholders include Dimensional Fund Advisors LP (6.22%), Renaissance Technologies LLC (5.79%), Rice Hall James & Associates LLC (2.13%) and Bank of New York Mellon Corp (1.01%).
View institutional ownership trends
.

Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Utah Medical Products investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and AUO (AUOTY).

Company Calendar

Record date for 4/3 Dividend
3/17/2026
Ex-Dividend for 4/3 Dividend
3/17/2026
Dividend Payable
4/03/2026
Last Earnings
4/23/2026
Today
5/31/2026
Record date for 7/3 Dividend
6/17/2026
Ex-Dividend for 7/3 Dividend
6/17/2026
Dividend Payable
7/03/2026
Next Earnings (Estimated)
7/23/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:UTMD
CIK
706698
Employees
180
Year Founded
1978

Profitability

EPS (Trailing Twelve Months)
$3.38
Trailing P/E Ratio
19.66
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$11.29 million
Net Margins
28.90%
Pretax Margin
35.79%
Return on Equity
9.13%
Return on Assets
8.86%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
28.64
Quick Ratio
26.15

Sales & Book Value

Annual Sales
$38.52 million
Price / Sales
5.49
Cash Flow
$4.46 per share
Price / Cash Flow
14.89
Book Value
$37.23 per share
Price / Book
1.78

Miscellaneous

Outstanding Shares
3,180,000
Free Float
2,929,000
Market Cap
$211.31 million
Optionable
Not Optionable
Beta
0.37

Social Links

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:UTMD) was last updated on 6/1/2026 by MarketBeat.com Staff.
From Our Partners